This week's roundup of Houston innovators includes Joanna Nathan of Prana Thoracic, Alfredo Arvide of Cloche, and Susan Davenport of the Greater Houston Partnership. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health tech to mobile ordering — recently making headlines in Houston innovation.

Joanna Nathan, CEO, and co-founder of Prana Thoracic

Prana Thoracic, an innovative startup in the lung cancer diagnostics space, has raised its series A round of investment. Photo via LinkedIn

Joanna Nathan has been busy. It's been just under six months since the launch of her company, Prana Thoracic, a Houston health tech startup tackling lung cancer diagnostics, and the company has already secured its next round of investment funding. A medical device company developing a tool for early interception of lung cancer, the company announced last week that it closed a $3 million series A financing round.

In August, the company received a $3 million award from the Cancer Prevention & Research Institute of Texas. All of Prana Thoracic's funding is being used to develop the unique diagnostic product and the company's path to first-in-human clinical studies.

“Our technology provides a definitive answer to patients with lung nodules and allows physicians to intervene earlier in the lung cancer patient’s journey,” says Joanna Nathan, CEO, and co-founder of Prana, in a news release. “Our team is grateful to have the support of our investors and excited to leverage this financing to accelerate our technology to the bedside.” Read more.

Alfredo Arvide, co-founder and managing director of Cloche

This new restaurant technology allows for eateries to upgrade to mobile ordering for no cost. Photo courtesy of Cloche

A new mobile software platform has launched in Houston and is currently looking for restaurants interested in utilizing their technology to upgrade their eatery with mobile ordering at no cost to the restaurant.

Alfredo Arvide, co-founder and managing director of Cloche, tells InnovationMap that the idea for the platform came after the pandemic forced restaurateurs to quickly pivot to touch-free menus. Now that the consumer has adapted to scanning QR codes to view menus, the next step is to optimize ordering — something that will also help with the labor shortages that restaurants are now facing.

"Now is the time transform this industry by creating a better meal experience for the consumers, an easier job for the restaurant staff and a more efficient, more profitable business for restaurant owners," Arvide says. Read more.Read more.

Susan Davenport, senior vice president and chief economic development officer for the Greater Houston Partnership

The Greater Houston Partnership's Susan Davenport shares details on Houston House at SXSW, HETI House at CERAWeek, and taking the city on tour to spread awareness of the ecosystem. Photo via houston.org

Every year, one of the biggest tech conferences in the world convenes right down the road from Houston in downtown Austin. That's a huge opportunity for the Greater Houston Partnership to showcase and congregate Housto's tech innovators.

Susan Davenport, senior vice president and chief economic development officer for the Greater Houston Partnership, shares on the Houston Innovators Podcast how the GHP has made an effort to increase Houston's presence at SXSW over the past few years. This year, the third year for Houston House, the GHP and the Houston Energy Transition Initiative are convening over 20 Houston innovators for two days of programming.

"We want to further the development of our ecosystem," Davenport says on the podcast. "Houston is so uniquely place for this — we have such well-developed industry sectors and a customer base. ... All entrepreneurs want to showcase their products and talk about what their doing. We'll have people there to answer questions and, most importantly, invite them to Houston." Read more and listen to the episode.

The Greater Houston Partnership's Susan Davenport shares details on Houston House at SXSW, HETI House at CERAWeek, and taking the city on tour to spread awareness of the ecosystem. Photo via houston.org

Tapping into CERAWeek, SXSW to showcase and convene Houston tech

Houston innovators podcast episode 176

Every year, one of the biggest tech conferences in the world convenes right down the road from Houston in downtown Austin. That's a huge opportunity for the Greater Houston Partnership to showcase and congregate Housto's tech innovators.

Susan Davenport, senior vice president and chief economic development officer for the Greater Houston Partnership, shares on the Houston Innovators Podcast how the GHP has made an effort to increase Houston's presence at SXSW over the past few years. This year, the third year for Houston House, the GHP and the Houston Energy Transition Initiative are convening over 20 Houston innovators for two days of programming.

"We want to further the development of our ecosystem," Davenport says on the podcast. "Houston is so uniquely place for this — we have such well-developed industry sectors and a customer base. ... All entrepreneurs want to showcase their products and talk about what their doing. We'll have people there to answer questions and, most importantly, invite them to Houston."

Currently, the GHP is also hosting its second year of involvement at CERAWeek with its HETI team. HETI House, which is open at CERAWeek showcases unique energy transition technology originating in Houston. Returning this year is HETI's startup pitch competition on March 8 from 10 am to 3 pm.

SXSW and CERAWeek are just two examples of the GHP's mission of putting Houston tech on display. Davenport shares how every year, the GHP's team embarks on a handful of domestic and international mission trips to bring Houston to other major cities — as well as bring back ideas from other ecosystems.

"We go to these conferences to provide a glimpse into what we're doing and have an opportunity to connect, but we also take that message around the globe," Davenport says. "We believe we have a great story. We believe Texas has a great backdrop, and we put all this together and take it on the road."

She shares more about these trips and on what people can expect from Houston House at SXSW on the podcast. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


According to a new report, Houston has potential to lead three life science subsectors: cell and gene therapy manufacturing, molecular diagnostics, and biologics drug development and manufacturing. Photo via Getty Images

Report: Houston is primed for a boom in these life science subsectors

by the numbers

A new report found that Houston has great potential across a handful of life science subsectors.

The study by Newmark Consulting Group was commissioned by the Greater Houston Partnership and sponsored by San Jacinto College, Lone Star College, Houston Community College, and McCord Development. It looked at the region's existing resources and value proposition in the life sciences sector.

According to the report, Houston is home to industry-leading expertise in three subsectors: cell and gene therapy manufacturing, molecular diagnostics, and biologics drug development and manufacturing.

From a workforce perspective, the city has a steady flow of new talent from regional universities and "an emerging and robust commitment by community colleges to support two-year degree pathways to meet industry demands and the ability for life science companies to grow and thrive in the market," per the report. The findings led to identifying the next steps for the Houston region to capitalize on these advantages.

“The Newmark study confirms what we knew to be true about the potential for life sciences growth in Houston,” says Susan Davenport, GHP's chief economic development officer, in a news release. “The study will help us coalesce our regional partners around a cohesive strategy to grow and expand the industry in Houston.”

The report's other key findings included:

  • Houston consistently ranks as a top-15 market for life sciences employment nationwide and first in Texas with nearly 700 life science companies operating in town.
  • The Bayou City has the densest patient population in the world, which allows for transformational clinical applications.
  • The city's diverse workforce, extensive university ecosystem, education infrastructure, and research institutions sets a scene for Houston to capture extensive subsector gains.
  • Houston ranks second in the nation in clinical trial volume with more than 4,600 currently active clinical trials, which is representing 15 percent of all active U.S. trials.
  • In 2021, Houston-area institutions attracted $864.1 million in grant funding from the National Institutes of Health, which is up 16.3 percent from 2020. On average over the past five years, the region received $740.7 million per year in NIH funding for a total of $3.9 billion.
  • Houston is home to more than 26,000 non-healthcare life science employees.
  • The region's life sciences workforce ranks No. 12 in the nation, on par with numbers reported for Research Triangle Park.
In light of the report, the GHP is recommending a few action items, including "accelerating workforce development programs to produce new graduates in key life sciences occupations, refining Houston’s marketing messages to highlight the region’s existing life science assets and activities within life science R&D and manufacturing," per the report. Additionally, the GHP identified the need to develop a shared regional strategy to attract and retain leading life sciences companies.
To lead these initiatives, the GHP has assembled task forces, which will be led by the organization’s Life Sciences Committee, chaired by Ferran Prat, senior vice president of Industry Relations and Research at MD Anderson Cancer Center.
This week's roundup of Houston innovators includes Eric Rubenstein of New Climate Ventures, Susan Davenport of Greater Houston Partnership, and Zimri T. Hinshaw of Bucha Bio. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from venture capital to sustainability — recently making headlines in Houston innovation.


Eric Rubenstein, founding managing partner of New Climate Ventures

Eric Rubenstein of New Climate Ventures joins the Houston Innovators Podcast to discuss the future of Houston as a clean energy hub. Photo courtesy of NCV

Houston has a big role to play in the energy transition, says Eric Rubenstein, a climatetech investor, on last week's episode of the Houston Innovators Podcast.

"Houston's role (within the energy transition) is multifaceted," he explains. "We have a talent pool here that fits pretty well in climate tech, alternative materials, and other spaces. ...We have a customer base here that is going to adopt these new technologies."

Rubenstein founded New Climate Ventures to fund startups within the sustainability and climate tech space — which includes technologies that address circular economy, sustainably made materials, clean energy, and more. Click here to read more and stream the episode.

Susan Davenport, chief economic development officer for the Greater Houston Partnership

The Greater Houston Partnership's Susan Davenport shares details on Houston House at SXSW. Photo via houston.org

Last year, the Greater Houston Partnership created virtual content to shine a spotlight on Houston tech and innovation at SXSW. This year, the GHP is taking that same initiative in-person and in Austin. Susan Davenport, chief economic development officer at GHP, shared in a Q&A what people can expect fro Houston House at SXSW.

"Anyone who is interested in technology, commercial aerospace, life sciences, and how DEI traverses with these industries will find value in our rockstar lineup of industry leaders, investors, and startup founders," she says. "We hope to see young professionals, entrepreneurs, investors, and executives."

The activation runs Sunday, March 13, and Monday, March 14. Click here to read more.

Zimri T. Hinshaw, CEO of Bucha Bio

Bucha Bio has arrived to make an impact on the city of Houston. Image via LinkedIn

A sustainable fashion company has relocated to Houston. Bucha Bio, founded in 2019, creates in textiles and composite materials made from bacterial nanocellulose, a much more sustainable materials production, that can be used instead of animal leather, polyurethane, latex, vinyl, epoxy, and more. The company announced in a press release today that it's moving from New York City and opening a next-gen materials headquarters at the East End Maker Hub. Bucha Bio has also been accepted as a member company at Greentown Labs.

According to the release, over 20 locations were considered, and Houston stood out for its hiring potential, local universities, Texas's business-friendly regulation, and more.

“We’ve signed on senior scientists and their experiences from the oil and plastic industry are perfectly suited to biomaterials,” says Zimri T. Hinshaw, CEO of Bucha Bio, in the release. Click here to read more.

The Greater Houston Partnership's Susan Davenport shares details on Houston House at SXSW. Photo via houston.org

GHP introduces in-person Houston House for SXSW 2022

Q&A

Texas is just about two weeks away from SXSW's return to in-person activations and events since pre-pandemic times. The two-week conference includes conversations and activities within music, film, education, tech, and more. And this year, the Greater Houston Partnership is shining a spotlight on the Bayou City at the festival.

"With the return of the conference in person for the first time since 2019, we are thrilled to build on that momentum and host Houston House — a two-day activation featuring programming and networking opportunities for guests attending the conference," says Susan Davenport, chief economic development officer for the GHP.

Houston House, which first originated last year in digital form, will be held in Austin on Sunday, March 13, and Monday, March 14. Davenport shares more details on the activation in a Q&A with InnovationMap.

InnovationMap: Why did the Greater Houston Partnership decide to have a presence at SXSW this year?

Susan Davenport: As one of the premier tech conferences in the U.S., SXSW provides an incredible platform to promote Houston’s position as the most prominent emerging innovation hub in the country.

Houston was a featured partner at last year’s SXSW Online Conference, where the Partnership rallied innovative leaders from across the region for a series of virtual programming. With the return of the conference in person for the first time since 2019, we are thrilled to build on that momentum and host Houston House – a two-day activation featuring programming and networking opportunities for guests attending the conference.

With an expected attendance of 45,000 bright minds from around the globe, it’s the perfect venue to showcase Houston’s tech leadership and cultivate relationships that support the growth of our ecosystem.

IM: What can attendees expect from Houston House?

SD: This year’s activation will be held at the Line Hotel, an established SXSW venue in the heart of the action. Consistent with what attendees have come to expect from South by, Houston House will offer thought leadership programming featuring industry leaders and startup founders in a series of panel discussions on today’s most prominent topics in tech.

In addition to main stage programming, Houston House will also offer a lounge space that will serve as a landing pad for stakeholders and attendees to cultivate relationships. Each day of programming will conclude with a networking reception.

IM: The programming is geared around a few topics — what are some of these themes and how do they pertain to Houston innovation?

SD: On Sunday, March 13, our programming will be focus on topics like commercial aerospace, medical device innovation, cell therapy, and investment for diverse entrepreneurs. These panel sessions will showcase Houston’s leadership through the incredible work taking place at the Ion, Houston Spaceport, Johnson Space Center, and the Texas Medical Center.

On Monday, March 14, our programming will kick off the start of the SXSW Climate Change track and focus primarily on how Houston is leveraging its energy leadership to accelerate solutions for a low-carbon future. Topics will include VC investment in climate tech, corporate and startup partnerships, emerging low-carbon energy technologies, and ensuring an equitable energy transition.

Our full lineup of Houston House programming and speakers can be found online, along with an overview of the 2022 SXSW Conference.

IM: Who should stop by Houston House at SXSW?

SD: Anyone who is interested in technology, commercial aerospace, life sciences, and how DEI traverses with these industries will find value in our rockstar lineup of industry leaders, investors, and startup founders. We hope to see young professionals, entrepreneurs, investors, and executives.

For fellow Houstonians attending the conference, Houston House will serve as a home base to kick off your SXSW experience. For those who are not currently involved in our tech ecosystem, this will be the perfect opportunity to dive in and learn more about the amazing things taking place in our great region.

------

This conversation has been edited for brevity and clarity.

A new report from the Greater Houston Partnership analyzes the city's startup ecosystem's banner year of VC activity. Photo via Getty Images

New analysis puts Houston's leap in venture capital investment in perspective

by the numbers

Houston-area startups raked in the cash last year, setting a record for the region’s annual tally of venture capital.

In 2021, Houston startups collected $2.02 billion in VC funding, according to a Greater Houston Partnership analysis of data from PitchBook. That’s up 175 percent from the $734.2 million raised in 2020.

Three startups (Solugen, HighRadius, and Lancium) accounted for more than $800 million of last year’s VC haul.

“This record year in venture capital funding for Houston companies is another important example of the positive momentum building around our innovation ecosystem,” says Susan Davenport, chief economic development officer for the Greater Houston Partnership.

“In just the last year alone, we saw the opening of The Ion, East End Maker Hub, Greentown Labs as well as the growth of other startup development organizations,” Davenport adds. “We also witnessed two of our startups — Solugen and Axiom Space — grow into unicorns, achieving a valuation of more than $1 billion. Add to this the expanded local presence of tech giants such as Microsoft, Amazon Web Services and Google Cloud, and it’s clear that Houston is rapidly building on its reputation as an innovation and technology hub.”

Here’s a breakdown of last year’s record-shattering year for VC in Houston.

Funding

  • $188.5 million in angel and seed funding, up 92.6 percent from $97.9 million in 2020.
  • $687.4 million in early-stage funding, up 361 percent from $149.1 million in 2020.
  • $1,144.3 billion in late-stage funding, up 134.9 percent from $487.3 million in 2020.

Deal volume

  • 219 deals, up 26.6 percent from up from 173 deals in 2020.
  • 122 angel and seed deals, up 9.9 percent from up from 111 deals in 2020.
  • 49 early-stage deals, up 58.1 percent from 31 deals in 2020.
  • 48 late-stage deals, up 54.8 percent from 31 deals in 2020.

Average deal size

$11.6 million average deal size, up 110.3 percent from $5.5 million in 2020.

Industries receiving the most VC in 2021

  • Information technology, $632.1 million.
  • Health care, $518.4 million.
  • Materials and resources, $426.5 million.

Serafina Lalany, executive director of Houston Exponential, told InnovationMap in January that tracking VC data offers her organization a metric for growth of the local innovation ecosystem.

“It gives us insights into the rate of capital that is deployed and how that’s growing over time and where it’s getting deployed. [It also] gives us the signal as to what our strengths are and the areas that we need to continue to build out infrastructure,” Lalany said.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.